Publications Database

Althaus M. et al. (2015)

Oxytocin enhances orienting to social information in a selective group of high-functioning male adults with autism spectrum disorder.

Neuropsychologia

December, 79 pp. 53-69.

Read Abstract (New Window)

Alvares G. A. , Quintana D. S. , Whitehouse A. J. (2017)

Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.

Autism Research

10 pp. 25–41.

Read Abstract (New Window) Read Full (New Window)

Anagnostou E. et al. (2014)

Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth.

Brain Research

pii: S0006-8993(14)00134-6

Read Abstract (New Window)

Anagnostou E. et al. (2012)

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.

Molecular Autism

3(16),

Read Abstract (New Window) Read Full (New Window)

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Andari E. et al. (2010)

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Proceedings of the National Academy of Science U S A

107(9), pp. 4389-4394

Read Abstract (New Window)

Auyeung B. et al. (2015)

Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism.

Translational Psychiatry

e. 507

Read Abstract (New Window) Read Full (New Window)

Bartz J. A. , Hollander E. (2008)

Oxytocin and experimental therapeutics in autism spectrum disorders.

Progress in Brain Research

170 pp. 451-462

Read Abstract (New Window)

Cai Q. , Feng L. , Yap K. Z.

Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder.

Psychiatry and Clinical Neurosciences

Read Abstract (New Window)

Canitano R. (2013)

Novel treatments in autism spectrum disorders: from synaptic dysfunction to experimental therapeutics.

Behavioural Brain Research

251 pp. 125-132.

Read Abstract (New Window)

Dadds M. R. et al. (2014)

Nasal oxytocin for social deficits in childhood autism: A randomized controlled trial.

Journal of Autism and Developmental Disorders

44(3), pp. 521-531.

Read Abstract (New Window)

DeFilippis M. (2018)

The use of complementary alternative medicine in children and adolescents with autism spectrum disorder.

Psychopharmacology Bulletin

48(1), pp. 40-63.

Read Abstract (New Window) Read Full (New Window)

DeMayo M. M. et al.

A review of the safety, efficacy and mechanisms of delivery of nasal oxytocin in children: Therapeutic potential for autism and Prader-Willi syndrome, and recommendations for future research.

Pediatric Drugs

Read Abstract (New Window)

Domes G. et al. (2013)

Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder.

Biological Psychiatry

74(3), pp. 164-171.

Read Abstract (New Window)

Farmer C. A. , Thurm A. , Grant P. J. (2013)

Pharmacotherapy for the core symptoms in autistic disorder: Current status of the research.

Drugs

73(4), pp. 303-314.

Read Abstract (New Window)

Fukai M. et al. (2017)

Oxytocin effects on emotional response to others' faces via serotonin system in autism: A pilot study.

Psychiatry Research: Neuroimaging

267 pp. 45-50.

Read Abstract (New Window)

Gürkana C. K. , Hagerman R. J. (2012)

Targeted treatments in autism and fragile X syndrome.

Research in Autism Spectrum Disorders

6(4), pp. 1311-1320.

Read Abstract (New Window)

Gordon I. et al. (2013)

Oxytocin enhances brain function in children with autism.

Proceedings of the National Academy of Science U S A

110(52), pp. 20953-20958.

Read Abstract (New Window) Read Full (New Window)

Green L. et al. (2001)

Oxytocin and autistic disorder: Alterations in peptide forms.

Biological Psychiatry

50 pp. 609-613.

Read Abstract (New Window)

Guastella A. J. et al. (2010)

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Biological Psychiatry

67(7), pp. 692-694

Read Abstract (New Window)